Log In
Print
BCIQ
Print
Print this Print this
 

LCZ696

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionCrystalline complex of valsartan and sacubitril in an equimolar ratio
Molecular Target Angiotensin II type 1 (AT1) receptor (AGTR1) ; Neutral endopeptidase (neprilysin) (MME) (NEP) (CD10)
Mechanism of ActionNeutral endopeptidase inhibitor; Angiotensin II type 1 (AT1) receptor (ATGR1) antagonist
Therapeutic ModalitySmall molecule: Combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today